A Deep Dive Into Value Unlock, Investor Journeys & Market Timing The NephroPlus IPO has arrived with remarkable buzz. And understandably so. After all, this isn’t merely another healthcare listing; rather, it’s the culmination of a decade-long journey powered by patient capital, strategic partnerships, and consistent scale-up. Moreover, the Offer for Sale (OFS) attached to…
Read more
Categories: Reports